Sushil Beriwal, Vice President of Varian Medical Affairs, shared a post on LinkedIn about a paper by Jonathan E. Leeman et al. published in Radiotherapy and Oncology:
“CBCT based online adaptive RT for prostate allows margin reduction and still ensuring coverage with this dosimetric benefit translating to reduction in acute toxicity.”
Title: CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatment
Authors: Lin L. Zhu, Jeremy S. Bredfeldt, Yue-Houng Hu, Cindy Hancox, Christian V. Guthier, Sarah Quirk, Jennifer Pursley, Sophia C. Kamran, David McClatchy, Paul L. Nguyen, Anthony V. D’Amico, Mutlay Sayan, Ellen Kim, Kent W. Mouw, Martin T. King, Neil E. Martin, Jonathan E. Leeman
You can read the full article in Radiotherapy and Oncology.
More posts about Prostate Cancer.